Certain Ordinary Shares of Akari Therapeutics, Plc are subject to a Lock-Up Agreement Ending on 16-JAN-2018. These Ordinary Shares will be under lockup for 90 days starting from 18-OCT-2017 to 16-JAN-2018. Details: The executive officers, directors, and RPC Pharma Limited have agreed that they will not to sell or transfer any of our ordinary shares or securities convertible into or exchangeable or exercisable for ordinary shares, which includes American Depositary Shares, for a period of 90 days after the date of the final prospectus without first obtaining the written consent of Cantor Fitzgerald & Co.